Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Diagnostic and Therapeutic Quandaries in a Patient with Primary Hepatic Lymphoma and Concurrent Hepatitis C Infection

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

Primary hepatic lymphoma (PHL) is a very rare sub-type of non-Hodgkin’s lymphoma and hepatitis C infection may be a contributory factor. The association of hepatitis C infection and PHL causes difficulties in management since safety of rituximab in such situations is unclear due to lack of evidence. The role of anti-viral therapy in combination with chemotherapy is also uncertain. We describe the diagnostic and therapeutic challenges posed by a patient who was diagnosed with PHL and concurrent hepatitis C infection.
Literature
1.
Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H et al (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297(18):2010–2017PubMedCrossRef
2.
3.
Gasparotto D, De Re V, Boiocchi M (2002) Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma 43(4):747–751PubMedCrossRef
4.
Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S (2004) B-cell non-Hodgkin’s lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 111(1):1–8PubMedCrossRef
5.
Bronowicki JP, Bineau C, Feugier P, Hermine O, Brousse N, Oberti F et al (2003) Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 37(4):781–787PubMedCrossRef
6.
Kikuma K, Watanabe J, Oshiro Y, Shimogama T, Honda Y, Okamura S et al (2012) Etiological factors in primary hepatic B-cell lymphoma. Int J Pathol 460(4):379–387
7.
Steller EJ, van Leeuwen MS, van Hillegersberg R, Schipper ME, Rinkes IH, Molenaar IQ (2012) Primary lymphoma of the liver—a complex diagnosis. World J Radiol 4(2):53–57PubMedCrossRefPubMedCentral
8.
9.
Visco C, Arcaini L, Brusamolino E, Burcheri S, Ambrosetti A, Merli M et al (2006) Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol 17(9):1434–1440PubMedCrossRef
10.
Ennishi D, Maeda Y, Niitsu N, Kojima M, Izutsu K, Takizawa J et al (2010) Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood 116(24):5119–5125PubMedCrossRef
11.
Niitsu N, Hagiwara Y, Tanae K, Kohri M, Takahashi N (2010) Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol 28(34):5097–5100PubMedCrossRef
12.
La Mura V, De Renzo A, Perna F, D’Agostino D, Masarone M, Romano M et al (2008) Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma. J Hepatol 49(4):557–563PubMedCrossRef
Metadata
Title
Diagnostic and Therapeutic Quandaries in a Patient with Primary Hepatic Lymphoma and Concurrent Hepatitis C Infection
Publication date
01-09-2014
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0431-z

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue

Case Report

Acute Cholecystitis in Thrombotic Thrombocytopenic Purpura

Case Report

Acute Soft Head Syndrome in Children with Sickle Cell Anaemia in Lagos, Nigeria

Case Report

Hepatosplenic T Cell Lymphoma: A Rare Case Report

Case Report

Precursor NK Cell Lymphoblastic Leukemia/Lymphoma—Report of a Case with Literature Review

Case Report

A Colonization of a Different Kind

Case Report

Autologous Immune Enhancement Therapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits